New developments in medicine are constantly unfolding, especially now with nuclear medicine and changing cancer treatment. One of the latest advancements is the use of a treatment called Pluvicto to treat metastatic castration-resistant prostate cancer. Ka Kit Wong, MBBS, a clinical professor of nuclear medicine, discusses Pluvicto as a treatment and what this means for future cancer treatments.
